M
Martín Ruiz Ortiz
Researcher at University of Córdoba (Spain)
Publications - 76
Citations - 475
Martín Ruiz Ortiz is an academic researcher from University of Córdoba (Spain). The author has contributed to research in topics: Medicine & Atrial fibrillation. The author has an hindex of 12, co-authored 50 publications receiving 394 citations.
Papers
More filters
Journal ArticleDOI
Inappropriate doses of direct oral anticoagulants in real-world clinical practice: prevalence and associated factors. A subanalysis of the FANTASIIA Registry.
Martín Ruiz Ortiz,Javier Muñiz,Paula Raña Míguez,Inmaculada Roldán,Francisco Marín,María Asunción Esteve-Pastor,Angel Cequier,Manuel Martínez-Sellés,Vicente Bertomeu,Manuel Anguita,Fantasiia Study Investigators +10 more
TL;DR: The prevalence and associated factors of inappropriate doses of direct oral anticoagulants (DOAC) in a national registry of patients of real clinical practice and several clinical factors can identify patients at risk of this situation are described.
Journal ArticleDOI
PronÓstico a corto y largo plazo de la endocarditis infecciosa en pacientes no usuarios de drogas por vía parenteral. Resultados durante un período dé 15 años (1987-2001)
Manuel Anguita Sánchez,Francisco Calvo,Juan Carlos Castillo Domínguez,Mónica Delgado Ortega,Dolores Mesa Rubio,Martín Ruiz Ortiz,Elías Romo Peña,José María Arizón del Prado,José Suárez de Lezo +8 more
TL;DR: El pronostico a corto and largo plazo of los pacientes with endocarditis infecciosa parece estar mejorando en nuestro medio en los ultimos anos, en comparacion with el of epocas mas antiguas.
Journal ArticleDOI
Predicción de eventos embólicos en pacientes con fibrilación auricular no valvular: evaluación del score CHADS 2 en una población mediterránea
Martín Ruiz Ortiz,Elías Romo,Dolores Mesa,Mónica Delgado,Manuel Anguita,Amador López Granados,Juan C. Castillo,José M. Arizón,José Suárez de Lezo +8 more
TL;DR: El indice CHADS 2 es valido para cuantificar el riesgo of eventos embolicos en una poblacion mediterranea de pacientes con FANV.
Journal ArticleDOI
Oral anticoagulation in nonvalvular atrial fibrillation in clinical practice: impact of CHADS(2) score on outcome.
Martín Ruiz Ortiz,Elías Romo,Dolores Mesa,Mónica Delgado,Manuel Anguita,Juan C. Castillo,José M. Arizón,José Suárez de Lezo +7 more
TL;DR: OAC is effective and safe in daily clinical practice in patients with NVAF and CHADS2 score ≧1.0, according to embolic risk evaluated by means of CHADS1 score, and in patients receiving oral anticoagulation (OAC).
Journal ArticleDOI
Short- and Long-Term Prognosis of Infective Endocarditis in Non-Injection Drug Users: Improved Results Over 15 Years (1987–2001)
Manuel Anguita Sánchez,Francisco Calvo,Juan Carlos Castillo Domínguez,Mónica Delgado Ortega,Dolores Mesa Rubio,Martín Ruiz Ortiz,Elías Romo Peña,José María Arizón del Prado,José Suárez de Lezo +8 more
TL;DR: Short-and long-term prognoses for patients with infective endocarditis appear to have improved over recent years at the authors' hospitals.